- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.8: 4 residues within 4Å:- Chain A: R.558, R.559, D.640, N.641
4 PLIP interactions:4 interactions with chain A- Water bridges: A:R.559, A:D.640
- Salt bridges: A:R.558, A:R.559
SO4.9: 4 residues within 4Å:- Chain A: T.106, E.107, E.108, R.109
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.108, A:R.109
- Water bridges: A:R.109
- Salt bridges: A:R.109
SO4.10: 3 residues within 4Å:- Chain A: R.620, R.646
- Chain B: S.207
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.620, A:R.646
SO4.18: 4 residues within 4Å:- Chain B: T.106, E.107, E.108, R.109
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:T.106, B:E.108, B:R.109
- Water bridges: B:E.108
- Salt bridges: B:R.109
SO4.19: 4 residues within 4Å:- Chain B: R.558, R.559, D.640, N.641
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.558, B:R.559
SO4.20: 4 residues within 4Å:- Chain A: E.206, S.207
- Chain B: R.620, R.646
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain A- Water bridges: B:R.620, B:R.620, A:S.207, A:S.207
- Salt bridges: B:R.620, B:R.646
- 2 x 2KV: 1-[cis-4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one(Non-covalent)
2KV.11: 14 residues within 4Å:- Chain A: R.87, E.167, E.168, S.171, F.319, Y.509, S.592, Y.593, V.618, W.621, Y.624, Y.628, V.673, H.702
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.319, A:F.319, A:Y.628, A:V.673
- Hydrogen bonds: A:E.168, A:Y.624
- pi-Stacking: A:Y.628
2KV.21: 14 residues within 4Å:- Chain B: R.87, E.167, E.168, S.171, F.319, Y.509, S.592, Y.593, V.618, W.621, Y.624, Y.628, V.673, H.702
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.319, B:F.319, B:Y.628, B:V.673
- Hydrogen bonds: B:E.167, B:E.168
- pi-Stacking: B:Y.628
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Namoto, K. et al., Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-02-12
- Peptides
- Dipeptidyl peptidase 4: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 2 x 2KV: 1-[cis-4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Namoto, K. et al., Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-02-12
- Peptides
- Dipeptidyl peptidase 4: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B